Counterpressure Maneuvers in Postural Orthostatic Tachycardia Syndrome
CPM_in_POTS
Physical Counterpressure Maneuvers in Postural Orthostatic Tachycardia Syndrome (POTS) - a Monocentric, Randomized Controlled Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
The present study evaluates whether performing a 14-days counter pressure maneuvers (CPM)-biofeedback training improves the symptomatic burden (primary objective) and secondarily the interference of POTS symptoms with daily activities, fatigue, and health-related quality of life of individuals with POTS compared to best clinical practice non-pharmacological measures. Secondary in-laboratory objectives are to assess the influence of CPM on the supine-to-standing heart rate (HR) and blood pressure (BP) changes as well as on the severity of orthostatic intolerance after performing CPM for two minutes compared to a baseline (intervention-free) active standing test, and to assess the safety and tolerability of CPM-biofeedback training in individuals with POTS. This is a monocentric, proof-of-concept, 1:1 randomized, controlled trial with rater-blinded evaluation of the hemodynamic effect of CPM in 40 individuals suffering from POTS. All study participants will receive detailed counselling on CPM and other behavioral and non-pharmacological measures to combat POTS symptoms in daily life and will be invited to practice them regularly (best clinical practice). Participants randomized to the interventional arm will receive a CPM-biofeedback training session in the autonomic function laboratory at the Department of Neurology of the Innsbruck Medical University to learn four different CPM under continuous HR and BP monitoring. The CPM-biofeedback training will consist of a baseline 2-minutes active standing and the following four different physical maneuver: leg crossing and muscle tensing, heel raises (10 tiptoeing per minute), squatting, unilateral handgrip (20 times a minute). The trial foresees three study visits for both the interventional and the control arm (screening and baseline on-site, as well as a telephone visit 14 days later). For the interventional trial arm, two additional visits are planned (CPM-biofeedback training session in the autonomic function laboratory and a follow-up telephone visit 7 days later). To evaluate the baseline to day-14 change in symptom severity, the Malmö POTS Score (MAPS) total score (primary endpoint) and the MAPS single items, Vanderbilt Orthostatic Symptom Score, Orthostatic Grading Scale, Fatigue Severity Scale and Health-related Quality of Life Questionnaire (EuroQol -EQ-5D-5L ) will be administered.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2025
CompletedFirst Submitted
Initial submission to the registry
March 28, 2025
CompletedFirst Posted
Study publicly available on registry
April 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMay 2, 2025
March 1, 2025
12 months
March 28, 2025
April 29, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Malmö Postural Orthostatic Tachycardia Syndrome symptom score (MAPS)
Baseline to day-14 change in the total score from 0 to 120. Higher scores means more symptoms and higher symptom severity.
Baseline to day-14
Secondary Outcomes (14)
Severity of orthostatic intolerance (on a 0 - 10 points scale)
After performing four different counterpressure maneuvers for two minutes each during the biofeedback session, at day 1 +/-3.
Absolute heart rate
At 15, 30, 60, 90 and 120 seconds during four different counterpressure maneuver practiced upon standing , at day 1 +/-3.
Absolute systolic and diastolic blood pressure
At 15, 30, 60, 90 and 120 seconds during counterpressure maneuver practiced upon standing, , at day 1 +/-3.
Supine-to-standing change in heart rate
At 15, 30, 60, 90 and 120 seconds during four different counterpressure maneuvers, at day 1 +/-3.
Supine-to-standing change in systolic and diastolic blood pressure
At 15, 30, 60, 90 and 120 seconds during four different counterpressure maneuvers, at day 1 +/-3.
- +9 more secondary outcomes
Study Arms (2)
Best clinical practice
ACTIVE COMPARATORCounselling on counterpressure maneuvers and other behavioral and non-pharmacological measures to combat POTS symptoms in daily life.
Best clinical practice plus CPM-biofeedback training
EXPERIMENTALIn addition to counselling on CPM and other behavioral and non-pharmacological measures to combat POTS symptoms in daily life, participants undergo a CPM-biofeedback training session in the autonomic function laboratory under continuous HR and BP monitoring.
Interventions
The CPM-biofeedback training consists of a baseline 2-minutes active standing and the following four different physical maneuver: leg crossing and muscle tensing, heel raises (10 tiptoeing per minute), squatting, unilateral handgrip (20 times per minute). All exercises will be performed under continuous heart rate and blood pressure monitoring to enable the study participants to gain feedbacks on the effect of the maneuvers on their own biosignals.
Recommendations about life-style and behavioural measures to mitigate POTS symptoms in daily life.
Eligibility Criteria
You may qualify if:
- POTS diagnosis
- to 80 years of age at time of consent
- stable medication in the seven days prior to the baseline visit
- able to provide written informed consent
You may not qualify if:
- participation in other interventional trials
- pregnant or breastfeeding females
- on treatment with vasoactive medications including medications for heart rate control
- acute infections at the time of enrolment or in the two weeks before
- acute pain
- surgery in the last three months
- inability or contraindication for performing hip and knee flexion, hip adduction or squatting
- inability to stand for at least two minutes
- Any other cardiological, internal, psychiatric or neurological condition, which may prevent engagement in the sturdy procedures in the judgement of the investigator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of Innsbruck
Innsbruck, Tyrol, A-6020, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 28, 2025
First Posted
April 20, 2025
Study Start
January 15, 2025
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
May 2, 2025
Record last verified: 2025-03